Anesthetized guinea pig as a model for drug testing.

Area of Science:

• Cardiovascular Pharmacology
• Preclinical Drug Development
• In Vivo Models

Background:

• Cardiovascular diseases are a leading global cause of mortality.
• Current treatments for cardiovascular diseases have limitations, necessitating new drug development.
• In vivo models are crucial for preclinical evaluation of novel therapeutic agents.

Purpose of the Study:

• To summarize the methodology of the anesthetized guinea pig model for cardiovascular drug testing.
• To evaluate the advantages, limitations, and risks associated with this model.
• To assess the efficacy of the model using substances with adrenergic activity.

Main Methods:

• Utilized an anesthetized guinea pig as a whole-body model.
• Evaluated complex cardiovascular system reactions to tested substances.
• Monitored electrocardiogram (ECG) parameters following administration of adrenergic agents.

Main Results:

• The anesthetized guinea pig model demonstrated suitability for assessing cardiovascular drug effects.
• The model allows for evaluation of complex cardiovascular system reactions.
• Results obtained from this model show good translatability to clinical medicine due to cardiomyocyte action potential similarity.

Conclusions:

• The anesthetized guinea pig model is a valuable and appropriate tool for preclinical testing of drugs targeting the cardiovascular system.
• This model aids in understanding drug effects on ECG parameters.
• The model's findings are relevant for clinical applications in cardiovascular medicine.